Britain Creo receives speedy FDA approval for its endoscopic device Britain’s Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch. The company, […]
